galactosamine has been researched along with Lung Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bone, RC; Chang, LW; Chowdhury, P; Rayford, PL | 1 |
| Bahrami, S; Leichtfried, G; Redl, H; Schlag, G; Yu, Y | 1 |
| Basalka, E; Lam, C; Schütze, E; Walzl, H | 1 |
3 other study(ies) available for galactosamine and Lung Diseases
| Article | Year |
|---|---|
Potentiation of Cd-induced pulmonary injury in alpha 1-antitrypsin suppressed rats.
Topics: alpha 1-Antitrypsin; Animals; Cadmium; Galactosamine; Lung; Lung Diseases; Rats; Rats, Inbred Strains | 1983 |
Similar cytokine but different coagulation responses to lipopolysaccharide injection in D-galactosamine-sensitized versus nonsensitized rats.
Topics: Animals; Bacterial Toxins; Disseminated Intravascular Coagulation; Dose-Response Relationship, Drug; Endotoxins; Escherichia coli; Galactosamine; Intestinal Diseases; Lipopolysaccharides; Liver Diseases; Lung Diseases; Male; Necrosis; Rats; Rats, Sprague-Dawley; Shock, Septic; Tumor Necrosis Factor-alpha | 1994 |
Protection of mice against lethal endotoxemia by lipid X is mediated through inhibition of neutrophil function.
Topics: Animals; Cell Aggregation; Galactosamine; Glucuronidase; Glycolipids; Humans; In Vitro Techniques; Lipid A; Lipopolysaccharides; Lung Diseases; Male; Mice; Mice, Inbred C57BL; Neutrophils; Shock, Septic; Superoxides | 1987 |